FDA Inspection 833837 - Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. - May 17, 2013

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc., with an inspection on May 17, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.
Inspection Date: May 17, 2013
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 36ebbabe-f6d5-4348-8b91-653621fd01ca

Violation Codes1

21 CFR 314.80(c)(1)(i)

Full citation text and observation details available on the Dashboard.